Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05718557 · ClinicalTrials.gov registry record · Phase 1

Study of PYX-106 in Solid Tumors

A Phase 1 study of Solid Tumor, sponsored by Pyxis Oncology.

Active
Registry status
Phase 1
Development phase
47
Enrollment target
20
Study locations

NCT05718557 is a Phase 1 study of Solid Tumor that is active but no longer recruiting, run by Pyxis Oncology. The registered enrollment target is 47 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (79% lower). The trial reports 20 study locations across 17 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05718557, a Phase 1 study of Solid Tumor, is active but no longer recruiting, sponsored by Pyxis Oncology.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
47 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of this study is to determine the recommended dose(s) of PYX-106 in participants with relapsed/refractory solid tumors.

Conditions Studied

Solid Tumor

Interventions

  • DRUG PYX-106

Study Locations (20)

Madrid

  • START Madrid - Hospital Universitario Fundación Jiménez Díaz - Madrid
  • Hospital Universitario 12 de Octubre - Madrid
  • HM Centro Integral Oncológico Clara Campal - Madrid

California

  • University of California San Diego - La Jolla
  • University of Southern California - Los Angeles

Arizona

  • HonorHealth Research Institute - Scottsdale

Colorado

  • SCRI- HealthOne Denver - Denver

Georgia

  • Winship Cancer Institute of Emory University - Atlanta

Illinois

  • University of Chicago Medicine - Chicago

Massachusetts

  • Dana-Farber Cancer Institute - Boston

Ohio

  • Gabrail Cancer and Research Center - Canton

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2023-05-23
Est. Completion 2026-05
Phase Phase 1

Sponsor

Pyxis Oncology

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05718557

The ClinicalTrials.gov registry entry for NCT05718557 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (79% lower). The listed sponsor is Pyxis Oncology, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which PYX-106 is the first listed.

NCT05718557 reports 20 study locations spanning 17 distinct geographic areas - top geographies include Madrid, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT05718557 about?

NCT05718557 is a clinical study titled "Study of PYX-106 in Solid Tumors". The primary objective of this study is to determine the recommended dose(s) of PYX-106 in participants with relapsed/refractory solid tumors.

What is the current status of trial NCT05718557?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 47 participants. The study started on 2023-05-23. Estimated completion is 2026-05.

What conditions does trial NCT05718557 study?

This clinical trial studies the following conditions: Solid Tumor.

What interventions are being tested in trial NCT05718557?

The interventions under investigation include: PYX-106 (DRUG).

Who is sponsoring clinical trial NCT05718557?

This trial is sponsored by Pyxis Oncology, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05718557 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumor

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.